SCHEMBL22714728

SCHEMBL22714728

COc1cc2c(cc1Cl)C(=O)CC(C)S2

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.78
KDM4E B2RXH2 4/20 0.78
HPGD P15428 2/20 0.78
KLK7 P49862 1/20 0.78
HTT P42858 1/20 0.38
PPOX P50336 1/20 0.36
TSHR P16473 1/20 0.36
ACHE P22303 1/20 0.36
MAPT P10636 2/20 0.35
HSP90AA1 P07900 1/20 0.35
PKM P14618 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
CCR6 P51684 1/20 0.35
CACNA1B Q00975 1/20 0.35
APBA1 Q02410 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
HTR2A P28223 4/20 0.34
HTR2C P28335 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9819024 0.84 KDM4E (0.61) ALDH1A1KDM4EHPGDKLK7NPSR1
SCHEMBL22714557 0.83 KDM4E (0.58) ALDH1A1KDM4EHPGDKLK7RAB9A
SCHEMBL22714572 0.73 KDM4E (0.77) ALDH1A1KDM4EHPGDKLK7HTT
SCHEMBL11024058 0.73 KDM4E (0.78) ALDH1A1KDM4EHPGDKLK7HTT
SCHEMBL12264118 0.73 KDM4E (0.78) ALDH1A1KDM4EHPGDKLK7HTT
SCHEMBL4096555 0.72 KDM4E (0.63) ALDH1A1KDM4EHPGDKLK7PPOX
SCHEMBL67751 0.72 KDM4E (0.54) ALDH1A1KDM4EHPGDKLK7HTT
SCHEMBL31355203 0.72 KDM4E (0.54) ALDH1A1KDM4EHPGDKLK7HTT
SCHEMBL9819009 0.72 PBRM1 (0.50) ALDH1A1KDM4EHPGDKLK7HTT
SCHEMBL22714620 0.70 KDM4E (0.59) ALDH1A1KDM4EHPGDKLK7HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020239656-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF HEPATITIS B GALAPAGOS NV (BE) 2020-12-03 WO disclosed
WO-2020239656-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF HEPATITIS B GALAPAGOS NV (BE) 2020-12-03 WO disclosed